- Forums
- ASX - By Stock
- MSB
- Ann: FDA Grants Orphan Drug Designation for Revascor
Ann: FDA Grants Orphan Drug Designation for Revascor, page-4
-
- There are more pages in this discussion • 269 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.05 |
Change
-0.020(1.88%) |
Mkt cap ! $1.187B |
Open | High | Low | Value | Volume |
$1.07 | $1.07 | $1.03 | $3.335M | 3.191M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 30148 | $1.04 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.05 | 85193 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 31386 | 1.040 |
17 | 97836 | 1.035 |
20 | 209276 | 1.030 |
27 | 508449 | 1.025 |
23 | 468145 | 1.020 |
Price($) | Vol. | No. |
---|---|---|
1.045 | 83450 | 17 |
1.050 | 120496 | 14 |
1.055 | 184349 | 13 |
1.060 | 145751 | 9 |
1.065 | 31300 | 3 |
Last trade - 12.59pm 21/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online